DEPACON vs PHENYTOIN SODIUM
Independent side-by-side comparison.
Possible drug interaction. DEPACON and PHENYTOIN SODIUM are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.
Rating
72/100
New
Pharmacy pays
—
$0.18 /mL
Type
RX
RX
Active ingredient
VALPROATE SODIUM
PHENYTOIN SODIUM
Manufacturer
Dosage forms
Injectable
Capsule, Injectable
Drug class
Anti-Epileptic Agent
Anti-Epileptic Agent
Boxed warning
None
None
Half-life
about 9 to 16 hours (the label's mean terminal, or elimination, half-life for valproate monotherapy after oral doses of 250 to 1,000 mg)
About 22 hours on average, ranging from 7 to 42 hours — but phenytoin does NOT have a single fixed half-life. It follows nonlinear, saturable (Michaelis-Menten) kinetics, so the half-life lengthens as the dose and blood level rise; the label warns that "small incremental doses may increase the half-life and produce very substantial increases in serum levels" once levels are in the upper range.
Treats
—
Tonic-Clonic Epilepsy, Temporal Lobe Epilepsy, Status Epilepticus
Frequently asked questions
What is the difference between Depacon and Phenytoin Sodium?
Depacon contains Valproate Sodium, while Phenytoin Sodium contains Phenytoin Sodium — they have different active ingredients.
Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.